What is metamisol?

Metamizol, also known as sodium metamisol, is a non -steroidal anti -inflammatory drug (NSAID) similar to aspirin and ibuprofen, which acts as an analgesic, which means it provides pain relief and antipyretic, which means that it reduces Fever. This medicine was originally available without a prescription in most countries, but since the age of 20, it was banned in more than 30 countries, when its use was associated with a rare but sometimes fatal condition called agranulocytosis. The real danger of using metamisol is a matter of scientific debate, and in many countries the drug is still available on the counter and is used as part of the pain and fever in hospitals. It is available in other countries, but only with a prescription. It is sold under many different brands, including Dipyrone, Analgin and novalgin.Snii Fever. It is still available at the counter in Spain, India, Mexico, Israel and Russia and many developing countries. In these countries it is often a popular medicine that is considered cheap and effective. MEtamizole is currently banned in the United States, Canada, Sweden, Japan, Australia and several other countries.

Agranulocytóza je velmi vážný stav charakterizovaný nízkým počtem bílých krvinek a potlačený imunitní systém. Those suffering from this condition are very sensitive to infections such as pneumonia and septicemia, also known as blood poisoning. Common symptoms include fever and sore throat, but are not present in all cases. This potentially fatal condition is a possible side effect not only of metamisol, but also several other drugs, including other NSAIDs such as naproxen, and commonly prescribed anti-psychotic dkoberec Klozapin.

Many scientific studies have been conducted on the connection between metamisol and agranulocytosis, but everyone disagrees with the risk of closing the condition in the use of the drug. Proponents of this drug believe that the risks were overvalued at the age of 70. Some recent stUdia concluded that the risk is comparable or even lower than the risk related to other drugs. Other studies, however, concluded that the risk of harmful side effects, including not only agranulocytosis, but also anaphylaxis and infant leukemia, is too large to be used. Those who are against the use of metamisol believe it is advantageous to use other medicines that are not associated with these risks.